[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2014 Analysis of the Italian Therapeutic Drug Monitoring (TDM) Market: Hospitals and Commercial Labs

November 2013 | 247 pages | ID: 2EB2CB07A4EEN
Venture Planning Group

US$ 1,960.00 US$ 2,450.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new 247-page report from Venture Planning Group provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.

During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

“2013 Therapeutic Drug Monitoring (TDM) Market in Italy: Hospitals and Commercial Labs” is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.

Contains 247 pages and 17 tables
INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Therapeutic Drug Monitoring Tests
  1. Overview
  2. Carbamazepine
  3. Cyclosporin
  4. Digoxin
  5. Everolimus
  6. Gentamicin
  7. Lamotrigine/Lamictal
  8. Levetiracetam
  9. Lidocaine
  10. Lithium
  11. Phenytoin
  12. NAPA/Procainamide
  13. Quinidine
  14. Sirolimus
  15. Tacrolimus
  16. Topirimate
  17. Theophylline
  18. Valproic Acid
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/Inverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
  1. Monoclonal and Polyclonal Antibodies
  2. Immunoassays
    a. Technological Principle
    d. Chemiluminescence
    c. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      EMIT
      Electrochemical
    d. Radioimmunoassays (RIA)
    e. Immunoprecipitation
    f. Affinity Chromatography
  3. Tandem Mass Spec
  4. IT and Automation
  5. Dry Chemistry
  6. Biosensors
D. Market Size, Growth and Major Supplier Shares

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott Laboratories
AdnaGen
Agilent Technologies
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio/Innogenetics
Instrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE

LIST OF TABLES

Major Companies Developing or Marketing TDM Tests
Major Companies Developing or Marketing Digoxin Tests
Major Companies Developing or Marketing Lithium Tests
Major Companies Developing or Marketing Phenytoin Tests
Major Companies Developing or Marketing Theophylline Tests
Major Companies Developing or Marketing Valproic Tests
Major Companies Developing or Marketing Biosensors for Genetic Disease Testing
Italy, Laboratories Performing TDM Tests By Market Segment
Italy, Hospital Laboratories Performing TDM Tests By Bed Size
Italy, Commercial/Private Laboratories Performing TDM Tests By Annual Test Volume
Italy, TDM Test Volume Forecast By Market Segment
Italy, Hospital Laboratories, TDM Test Volume Forecast by Assay
Italy, Commercial/Private Laboratories, TDM Test Volume Forecast by Assay
Italy, TDM Reagent Market Forecast By Market Segment
Italy, Hospital Laboratories, TDM Reagent Market Forecast by Assay
Italy, Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
Italy, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares


More Publications